Evidence map›Paper›PMID 30824746›Full record

ArticleScientific reports2019

A Naturally Occurring Polymorphism in the HIV-1 Tat Basic Domain Inhibits Uptake by Bystander Cells and Leads to Reduced Neuroinflammation.

Arthur P Ruiz, David O Ajasin, Santhamani Ramasamy, Vera DesMarais, Eliseo A Eugenin, Vinayaka R Prasad

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Arthur P RuizDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA.
David O AjasinDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA.
Santhamani RamasamyDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA.
Vera DesMaraisAnalytical Imaging Facility, Albert Einstein College of Medicine, Bronx, NY, USA.
Eliseo A EugeninDepartment of Neuroscience, Cell Biology and Anatomy, University of Texas Medical Branch, Galveston, TX, USA.
Vinayaka R PrasadDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA. vinayaka.prasad@einstein.yu.edu.ORCID 0000-0002-9461-0189
Albert Einstein College of Medicine · USThe University of Texas Medical Branch at Galveston · US

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI THOMAS E ROHAN · 1985 to 2026
$111.2M
TRAINING PROGRAM IN CELLULAR &MOLEC. BIOLOGY &GENETICST32GM007491 · NIGMS · YESHIVA UNIVERSITY · PI QUERY, CHARLES C · 1985 to 2021
$17.0M
Training in HIV/AIDS Pathogenesis; Basic and Translational ResearchT32AI007501 · NIAID · YESHIVA UNIVERSITY · PI PRASAD, VINAYAKA R. · 1995 to 2024
$6.6M
The role of viral and cellular proteins in early events of HIV-1 replicationR37AI030861 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI PRASAD, VINAYAKA R. · 2007 to 2016
$4.4M
Role of pannexin-1 hemichannels in NeuroAIDSR01NS105584 · NINDS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI EUGENIN, ELISEO A · 2017 to 2021
$3.2M
Dissecting the Role of HIV-1 Tat & Chemokine Axis in Subtype-Specificity of HADR01MH083579 · NIMH · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI PRASAD, VINAYAKA R. · 2008 to 2012
$2.9M
Interplay of host factors that modulate HIV-1 release and replication fitnessF31AI127295 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI AJASIN, DAVID OLANREWAJU · 2017 to 2018
$87k
NCI NIH HHS P30 CA013330NIAID NIH HHS F31 AI127295NIAID NIH HHS R37 AI030861NIAID NIH HHS T32 AI007501NIGMS NIH HHS T32 GM007491NIMH NIH HHS R01 MH083579NINDS NIH HHS R01 NS105584
6 · The paper itself

Abstract

HIV-1 Tat protein contributes to HIV-neuropathogenesis in several ways including its ability to be taken up by uninfected bystander CNS cells and to activate inflammatory host genes causing synaptic injury. Here, we report that in the globally dominant HIV-1 clade C, Tat displays a naturally occurring polymorphism, R57S, in its basic domain, which mediates cellular uptake. We examined the effect of this polymorphism on Tat uptake and its consequences for cellular gene transactivation. In decapeptides corresponding to the basic domain, a R57S substitution caused up to a 70% reduction in uptake. We also used a transcellular Tat transactivation assay, where we expressed Tat proteins of HIV-1 clade B (Tat-B) or C (Tat-C) or their position 57 variants in HeLa cells. We quantified the secreted Tat proteins and measured their uptake by TZM-bl cells, which provide readout via an HIV-1 Tat-responsive luciferase gene. Transactivation by Tat-B was significantly reduced by R57S substitution, while that of Tat-C was enhanced by the reciprocal S57R substitution. Finally, we exposed microglia to Tat variants and found that R57 is required for maximal neuroinflammation. The R57S substitution dampened this response. Thus, genetic variations can modulate the ability of HIV-1 Tat to systemically disseminate neuroinflammation.

Indexed as

Bystander EffectHIV-1MicrogliaNeuronsPolymorphism, Genetictat Gene Products, Human Immunodeficiency VirusHeLa CellsHumansInflammationProtein Domainstat Gene Products, Human Immunodeficiency Virus

Identifiers

PMID30824746
PMCPMC6397180
OpenAlexW2918168452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.